
Sign up to save your podcasts
Or
Dr. Ozlem Tureci and Dr. Ugur Sahin, the co-founders of BioNTech, are behind the first coronavirus vaccine to be approved in the West. Starting next week, the “Pfizer vaccine” will be available in Britain.
While Pfizer is financing and distributing the vaccine, the science behind it was actually spearheaded by the couple’s lesser-known company. When Drs. Tureci and Sahin, along with their BioNTech team, embarked on this mission, the record for the fastest vaccine creation was four years. They did it in less than one.
BioNTech started working on a vaccine in January. By early November, the company shared the results of its Phase 3 trials: over 90 percent efficacy. The announcement was made days after the presidential election was called for Joe Biden, and Donald Trump claimed the timing was politically motivated.
In this episode of “Sway,” the couple dismiss that accusation and speak instead to the science. “Clinical trials are highly regulated,” Dr. Tureci says. “And this is something which you cannot really delay or stop or expedite.”
You can find transcripts (posted midday) and more information for all episodes at nytimes.com/sway, and you can find Kara on Twitter @karaswisher.
Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify.
3.7
6565 ratings
Dr. Ozlem Tureci and Dr. Ugur Sahin, the co-founders of BioNTech, are behind the first coronavirus vaccine to be approved in the West. Starting next week, the “Pfizer vaccine” will be available in Britain.
While Pfizer is financing and distributing the vaccine, the science behind it was actually spearheaded by the couple’s lesser-known company. When Drs. Tureci and Sahin, along with their BioNTech team, embarked on this mission, the record for the fastest vaccine creation was four years. They did it in less than one.
BioNTech started working on a vaccine in January. By early November, the company shared the results of its Phase 3 trials: over 90 percent efficacy. The announcement was made days after the presidential election was called for Joe Biden, and Donald Trump claimed the timing was politically motivated.
In this episode of “Sway,” the couple dismiss that accusation and speak instead to the science. “Clinical trials are highly regulated,” Dr. Tureci says. “And this is something which you cannot really delay or stop or expedite.”
You can find transcripts (posted midday) and more information for all episodes at nytimes.com/sway, and you can find Kara on Twitter @karaswisher.
Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify.
3,857 Listeners
1,469 Listeners
38,189 Listeners
6,670 Listeners
8,873 Listeners
9,257 Listeners
138 Listeners
2,060 Listeners
111,917 Listeners
1,499 Listeners
12,633 Listeners
302 Listeners
6,866 Listeners
469 Listeners
52 Listeners
2,318 Listeners
380 Listeners
1,450 Listeners
6,671 Listeners
5,462 Listeners
15,335 Listeners
1,494 Listeners
1,471 Listeners
7 Listeners
3,364 Listeners
20 Listeners
10 Listeners
459 Listeners
0 Listeners
36 Listeners
8 Listeners